Smart dosing cuts kidney risk in sick kids
NCT ID NCT04666948
First seen Jan 28, 2026 · Last updated May 15, 2026 · Updated 14 times
Summary
This study tested whether using a computer model to personalize vancomycin doses helps critically ill children reach the right drug levels faster and with fewer kidney problems. Over 300 children in intensive care took part. The goal was to improve treatment and reduce side effects compared to standard dosing.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VANCOMYCIN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AZ Sint-Jan Brugge-Oostende AV
Bruges, Belgium
-
Cliniques universitaires de Saint Luc
Brussels, Belgium
-
Erasme
Brussels, Brussels Capital, Belgium
-
Ghent University Hospital
Ghent, Belgium
-
Hopital universitaire de Reine Fabiola
Brussels, Belgium
-
UZ Brussel
Brussels, Belgium
-
UZ Leuven
Leuven, Belgium
Conditions
Explore the condition pages connected to this study.